Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of GW483100 vs Reference Montelukast in Healthy Volunteers
NCT02658422Phase 1Completed
- Sponsor
- GSK
- Start
- Aug 2015
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of montelukast in asthma and allergic rhinitis (AR) (2 arms), sponsored by GSK. Primary endpoints: Area under the concentration versus time from time zero to infinity, Area under the concentration-time curve from time zero to the last measurable concentration and 1 more. Started Aug 2015; status: completed.
02
Drugs
montelukast
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02658422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02658422.